CG
MYOV

Cutler Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Cutler Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,400
Closed -$27K – 5064
2022
Q4 		$27K Buy
23,400
+12,000
+105% +$316K ﹤0.01% 2020
2022
Q3 		$14K Sell
11,400
-1,000
-8% -$16K ﹤0.01% 2914
2022
Q2 		$7K Buy
12,400
+400
+3% +$4.41K ﹤0.01% 3531
2022
Q1 		$12K Buy
+12,000
New +$161K ﹤0.01% 3510
2021
Q1 		– Sell
-2,800
Closed -$19K – 6536
2020
Q4 		$19K Sell
2,800
-7,400
-73% -$144K ﹤0.01% 2735
2020
Q3 		$1K Buy
10,200
+2,000
+24% +$37.2K ﹤0.01% 4530
2020
Q2 		$36K Sell
8,200
-300
-4% -$4.08K ﹤0.01% 1994
2020
Q1 		$2K Sell
8,500
-400
-4% -$4.49K ﹤0.01% 3596
2019
Q4 		$28K Buy
+8,900
New +$89.7K ﹤0.01% 2017

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cutler Group's MYOV Position: Q1 2023 in Review

Cutler Group sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 5,359 shares — an estimated $144K sold.

Cutler Group first reported a position in MYOV in Q1 2020 and held it in 9 quarters. The position peaked at $144K in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Cutler Group reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5,359 Myovant Sciences Ltd. shares in Q1 2023, an estimated $144K.
  • Cutler Group first reported a position in Myovant Sciences Ltd. in Q1 2020 and held it in 9 quarters.
  • Cutler Group's Myovant Sciences Ltd. position peaked at $144K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.